124 related articles for article (PubMed ID: 33626534)
1. Prediction of Recurrence in Patients with Stage III Colon Cancer Using Conventional Clinicopathological Factors and Peripheral Blood Test Data: A New Analysis with Artificial Intelligence.
Kamei Y; Takayama T; Suzuki T; Furihata K; Otsuki M; Sadahiro S
Oncology; 2021; 99(5):318-326. PubMed ID: 33626534
[TBL] [Abstract][Full Text] [Related]
2. Factors predicting oncologic outcomes in patients with fewer than 12 lymph nodes retrieved after curative resection for colon cancer.
Huh JW; Kim CH; Kim HR; Kim YJ
J Surg Oncol; 2012 Feb; 105(2):125-9. PubMed ID: 21837680
[TBL] [Abstract][Full Text] [Related]
3. Lymph node CXCL17 messenger RNA: A new prognostic biomarker for colon cancer.
Rashad Y; Olsson L; Israelsson A; Öberg Å; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
Tumour Biol; 2018 Sep; 40(9):1010428318799251. PubMed ID: 30198422
[TBL] [Abstract][Full Text] [Related]
4. A Novel Prediction Model for Colon Cancer Recurrence Using Auto-artificial Intelligence.
Mazaki J; Katsumata K; Ohno Y; Udo R; Tago T; Kasahara K; Kuwabara H; Enomoto M; Ishizaki T; Nagakawa Y; Tsuchida A
Anticancer Res; 2021 Sep; 41(9):4629-4636. PubMed ID: 34475091
[TBL] [Abstract][Full Text] [Related]
5. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
Kim CG; Ahn JB; Jung M; Beom SH; Heo SJ; Kim JH; Kim YJ; Kim NK; Min BS; Koom WS; Kim H; Roh YH; Ma BG; Shin SJ
Ann Surg Oncol; 2017 Jan; 24(1):227-235. PubMed ID: 27699609
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic value and initial exploratory research on TNM staging method of tumor deposits in stage III colon cancer].
Qin Q; Yang L; Zhou AP; Wang JW; Zhong DS
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1152-1158. PubMed ID: 31874531
[No Abstract] [Full Text] [Related]
7. Identification of the Risk Factors for Recurrence of Stage III Colorectal Cancer.
Neki K; Eto K; Kosuge M; Ohkuma M; Ito D; Takeda Y; Yatabe S; Sugano H; Yanaga K
Anticancer Res; 2019 Oct; 39(10):5721-5724. PubMed ID: 31570473
[TBL] [Abstract][Full Text] [Related]
8. Preoperative serum markers for individual patient prognosis in stage I-III colon cancer.
Giessen-Jung C; Nagel D; Glas M; Spelsberg F; Lau-Werner U; Modest DP; Schulz C; Heinemann V; Di Gioia D; Stieber P
Tumour Biol; 2015 Sep; 36(10):7897-906. PubMed ID: 25953265
[TBL] [Abstract][Full Text] [Related]
9. Oncologic Outcomes of Colon Cancer Patients with Extraregional Lymph Node Metastasis: Comparison of Isolated Paraaortic Lymph Node Metastasis with Resectable Liver Metastasis.
Bae SU; Han YD; Cho MS; Hur H; Min BS; Baik SH; Lee KY; Kim NK
Ann Surg Oncol; 2016 May; 23(5):1562-8. PubMed ID: 26714940
[TBL] [Abstract][Full Text] [Related]
10. High preoperative serum carcinoembryonic antigen predicts metastatic recurrence in potentially curative colonic cancer: results of a five-year study.
Wiratkapun S; Kraemer M; Seow-Choen F; Ho YH; Eu KW
Dis Colon Rectum; 2001 Feb; 44(2):231-5. PubMed ID: 11227940
[TBL] [Abstract][Full Text] [Related]
11. Determinants of lymph node count and positivity in patients undergoing surgery for colon cancer.
Dolan RD; McSorley ST; Horgan PG; McMillan DC
Medicine (Baltimore); 2018 Mar; 97(13):e0185. PubMed ID: 29595652
[TBL] [Abstract][Full Text] [Related]
12. Beyond the NCCN Risk Factors in Colon Cancer: An Evaluation in a Swedish Population-Based Cohort.
Osterman E; Mezheyeuski A; Sjöblom T; Glimelius B
Ann Surg Oncol; 2020 Apr; 27(4):1036-1045. PubMed ID: 31893351
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of Serum Carcinoembryonic Antigen Levels after Curative Resection of Colon Cancer: Cutoff Values Determined according to Preoperative Levels Enhance the Diagnostic Accuracy for Recurrence.
Saito G; Sadahiro S; Kamata H; Miyakita H; Okada K; Tanaka A; Suzuki T
Oncology; 2017; 92(5):276-282. PubMed ID: 28178692
[TBL] [Abstract][Full Text] [Related]
14. Impact of lymph node retrieval and pathological ultra-staging on the prognosis of stage II colon cancer.
Law CH; Wright FC; Rapanos T; Alzahrani M; Hanna SS; Khalifa M; Smith AJ
J Surg Oncol; 2003 Nov; 84(3):120-6. PubMed ID: 14598354
[TBL] [Abstract][Full Text] [Related]
15. Predictive modelling for high-risk stage II colon cancer using auto-artificial intelligence.
Ishizaki T; Mazaki J; Enomoto M; Udo R; Tago T; Kasahara K; Nagakawa Y
Tech Coloproctol; 2023 Mar; 27(3):183-188. PubMed ID: 36031650
[TBL] [Abstract][Full Text] [Related]
16. Predictive factor of recurrence after curative resection for stage I-II colon cancer.
Dougaz W; Bouasker I; Gouta EL; Khalfallah M; Oueslati A; Samaali I; Ghariani W; Jerraya H; Nouira R; Dziri C
Tunis Med; 2019 May; 97(5):685-691. PubMed ID: 31729741
[TBL] [Abstract][Full Text] [Related]
17. Improved prediction of recurrence after curative resection of colon carcinoma using tree-based risk stratification.
Radespiel-Tröger M; Hohenberger W; Reingruber B
Cancer; 2004 Mar; 100(5):958-67. PubMed ID: 14983491
[TBL] [Abstract][Full Text] [Related]
18. Lymphatic Permeation Predicts Systemic Recurrence in Combination with Vascular Involvement in Laparoscopically Resected N0 Colon Cancer.
Kojo K; Katoh H; Naito M; Yamashita K; Nakamura T; Sato T; Yamanashi T; Watanabe M
Am Surg; 2017 Dec; 83(12):1394-1400. PubMed ID: 29336761
[TBL] [Abstract][Full Text] [Related]
19. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
Wu F; Chen L; Wu W; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
[TBL] [Abstract][Full Text] [Related]
20. Left colon as a novel high-risk factor for postoperative recurrence of stage II colon cancer.
Wang L; Hirano Y; Ishii T; Kondo H; Hara K; Obara N; Yamaguchi S
World J Surg Oncol; 2020 Mar; 18(1):54. PubMed ID: 32160919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
